A Dose-ranging Study to Investigate Efficacy of Buntanetap in Mild to Moderate AD
Part of paid clinical trials in Gilbert, Arizona.
- Sponsor
- Annovis Bio Inc.
- Study ID
- NCT05686044
- Phase
- PHASE2/PHASE3
- Status
- Completed
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 55 Years - 85 Years
- Healthy Volunteers
- Not accepted
Interventions
- Buntanetap/Posiphen — DRUGHPMC (vegetarian source) capsule shells
- Placebo — DRUGHPMC (vegetarian source) capsule shells
Study Details
The purpose of this study is to measure efficacy and safety of three different doses of buntanetap/Posiphen compared with placebo in participants with mild to moderate Alzheimer's disease. Study details include: The double-blind treatment duration will include a screening period of up to 42 days followed by 12 weeks of treatment at home. The study duration will be 4-5 months. There will be 4 in-clinic visits and 1 phone call.
Key Dates
- Start date
- Apr 1, 2023
- Status verified
- Apr 2025
- Primary completion
- Feb 13, 2024
- Completion
- Feb 13, 2024
Study Design
- Enrollment
- 351 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: 7.5mg Buntanetap/PosiphenBuntanetap/Posiphen 7.5mg oral capsule with daily administration for a period of 12 weeks
- Experimental: 15mg Buntanetap/PosiphenBuntanetap/Posiphen 15mg oral capsule with daily administration for a period of 12 weeks
- Experimental: 30mg Buntanetap/PosiphenBuntanetap/Posiphen 30mg oral capsule with daily administration for a period of 12 weeks
- Placebo Comparator: PlaceboPlacebo oral capsule with daily administration for a period of 12 weeks
Primary Outcome Measure
Change From Baseline to Week 12 in ADAS-Cog11 [ Time Frame: Baseline to the end of treatment period (12 weeks) ]
Locations (54)
Related coverage on Hipa.ai
- Buntanetap 15mg Shows Greater ADAS-Cog11 Improvement in Alzheimer's Trialbuntanetap/posiphen · Apr 29, 2025 · ClinicalTrials.gov
Find similar trials in Gilbert, AZ
By condition
By specialty
By research site
Related Studies
- Alzheimer's Disease Genetics StudyRecruiting · Indiana University · Nationwide, Indiana
- GeneMatch: A Program of the Alzheimer's Prevention Registry to Match Individuals to Studies Based on Apolipoprotein E (APOE) GenotypeEnrolling By Invitation · Banner Health · Phoenix, Arizona
- Neurologic Stem Cell Treatment StudyRecruiting · MD Stem Cells · Westport, Connecticut
- Nighttime Agitation and Restless Legs Syndrome in People With Alzheimer's DiseasePHASE4 · Recruiting · University of Texas at Austin · Austin, Texas